Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Modi, Shanu, Jacot, William, Yamashita, Toshinari, Sohn, Joohyuk, Vidal, Maria, Tokunaga, Eriko, Tsurutani, Junji, Ueno, Naoto T., Prat, Aleix, Chae, Yee Soo, Lee, Keun Seok, Niikura, Naoki, Park, Yeon Hee, Xu, Binghe, Wang, Xiaojia, Gil-Gil, Miguel, Li, Wei, Pierga, Jean-Yves, Im, Seock-Ah, Moore, Halle C.F., Rugo, Hope S., Yerushalmi, Rinat, Zagouri, Flora, Gombos, Andrea, Kim, Sung-Bae, Liu, Qiang, Luo, Ting, Saura, Cristina, Schmid, Peter, Sun, Tao, Gambhire, Dhiraj, Yung, Lotus, Wang, Yibin, Singh, Jasmeet, Vitazka, Patrik, Meinhardt, Gerold, Harbeck, Nadia, Cameron, David A.
Published in The New England journal of medicine (07.07.2022)
Published in The New England journal of medicine (07.07.2022)
Get full text
Journal Article
Pharmacokinetics of quinacrine in the treatment of prion disease
Yung, Lotus, Huang, Yong, Lessard, Pierre, Legname, Giuseppe, Lin, Emil T, Baldwin, Michael, Prusiner, Stanley B, Ryou, Chongsuk, Guglielmo, B Joseph
Published in BMC infectious diseases (29.11.2004)
Published in BMC infectious diseases (29.11.2004)
Get full text
Journal Article
Trastuzumab deruxtecan (T-DXd) versus treatment of physician’s choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): Results of DESTINY-Breast04, a randomized, phase 3 study
Modi, Shanu, Jacot, William, Yamashita, Toshinari, Sohn, Joohyuk, Vidal, Maria, Tokunaga, Eriko, Tsurutani, Junji, Ueno, Naoto T., Chae, Yee Soo, Lee, Keun Seok, Niikura, Naoki, Park, Yeon Hee, Wang, Xiaojia, Xu, Binghe, Gambhire, Dhiraj, Yung, Lotus, Meinhardt, Gerold, Wang, Yibin, Harbeck, Nadia, Cameron, David A.
Published in Journal of clinical oncology (10.06.2022)
Published in Journal of clinical oncology (10.06.2022)
Get full text
Journal Article
Safety and efficacy of cryopreserved autologous tumor infiltrating lymphocyte therapy (LN-144, lifileucel) in advanced metastatic melanoma patients who progressed on multiple prior therapies including anti-PD-1
Sarnaik, Amod, Khushalani, Nikhil I., Chesney, Jason Alan, Kluger, Harriet M., Curti, Brendan D., Lewis, Karl D., Thomas, Sajeve Samuel, Whitman, Eric D., Hamid, Omid, Lutzky, Jose, Pavlick, Anna C., Weber, Jeffrey S., Larkin, James M.G., Barton, Debora, Yung, Lotus, Suzuki, Sam, Fardis, Maria, Kirkwood, John M.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
APACT: Phase III randomized trial of adjuvant treatment with nab -paclitaxel ( nab -P) plus gemcitabine (Gem) versus Gem alone in patients (pts) with resected pancreatic cancer (PC)
Tempero, Margaret A., Cardin, Dana Backlund, Goldstein, David, O'Reilly, Eileen Mary, Philip, Philip Agop, Riess, Hanno, Macarulla, Teresa, Yung, Lotus, Li, Mingyu, Lu, Brian D., Biankin, Andrew
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article
Abstract HER2-18: HER2-18 Determination of HER2-low status in tumors of patients with unresectable and/or metastatic breast cancer in DESTINY-Breast04
Prat, Aleix, Modi, Shanu, Tsurutani, Junji, Cameron, David, Harbeck, Nadia, Garrido, Charo, Karnoub, Maha, Hsu, Ching, Feng, Wenquin, Yung, Lotus, Wang, Yibin, Gambhire, Dhiraj, Ford, Shirin K., Vitazka, Patrik, Ueno, Naoto T.
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
nab -paclitaxel ( nab -P) plus gemcitabine (Gem) vs Gem alone as adjuvant treatment for resected pancreatic cancer (PC) in a phase III trial (APACT)
Tempero, Margaret A., Cardin, Dana Backlund, Biankin, Andrew, Goldstein, David, Moore, Malcolm, O'Reilly, Eileen Mary, Philip, Philip Agop, Riess, Hanno, Macarulla, Teresa, Yung, Lotus, Li, Mingyu, Lu, Brian
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Tu1953 Nab-Paclitaxel Plus Gemcitabine vs Gemcitabine Alone for Resected Pancreatic Cancer in a Phase III Trial (APACT)
Tempero, Margaret, Cardin, Dana, Biankin, Andrew V, Goldstein, David, Moore, Malcolm, O'Reilly, Eileen, Philip, Philip, Riess, Hanno, Macarulla, Teresa, Yung, Lotus, Li, Mingyu, Lu, Brian
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2015)
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2015)
Get full text
Journal Article
Abstract P1-11-01: Trastuzumab deruxtecan vs treatment of physician’s choice in patients with HER2-low unresectable and/or metastatic breast cancer: Subgroup analyses from DESTINY-Breast04
Harbeck, Nadia, Modi, Shanu, Jacot, William, Yamashita, Toshinari, Sohn, Joo Hyuk, Vidal, Maria, Tsurutani, Junji, Ueno, Naoto T., Prat, Aleix, Niikura, Naoki, Xu, Binghe, Rugo, Hope, Papazisis, Konstantinos, Cortés, Javier, Krop, Ian, Gambhire, Dhiraj, Yung, Lotus, Wang, Yibin, Singh, Jasmeet, Cameron, David
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
APACT: A Phase III Trial of Nab-Paclitaxel (nab-P) Plus Gemcitabine (Gem) Versus Gem Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (PC): 232
Tempero, Margaret, Cardin, Dana, Biankin, Andrew, Goldstein, David, Moore, Malcolm, O’Reilly, Eileen, Philip, Philip, Riess, Hanno, Macarulla, Teresa, Yung, Lotus, Wei, Xinyu, Lu, Brian
Published in The American journal of gastroenterology (01.10.2014)
Published in The American journal of gastroenterology (01.10.2014)
Get full text
Journal Article
APACT: A phase 3 randomized, open-label, multicenter trial evaluating the use of adjuvant nab -paclitaxel ( nab -P) plus gemcitabine (G) versus G alone in patients (pts) with surgically resected ductal pancreatic adenocarcinoma (PDA)
Tempero, Margaret A., Cardin, Dana Backlund, Biankin, Andrew, Goldstein, David, Moore, Malcolm, O'Reilly, Eileen Mary, Philip, Philip Agop, Riess, Hanno, Macarulla, Teresa, Yung, Lotus, Wei, Xinyu, Lu, Brian
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastoma
Reardon, David A., Cloughesy, Timothy, Rich, Jeremy, Alfred Yung, W. K., Yung, Lotus, DiLea, Clifford, Huang, Jerry, Dugan, Margaret, Mietlowski, William, Maes, Andrea, Conrad, Charles
Published in Cancer chemotherapy and pharmacology (2012)
Published in Cancer chemotherapy and pharmacology (2012)
Get full text
Journal Article
Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumors
Chen, Nianhang, Chawla, Sant P., Chiorean, Elena Gabriela, Read, William L., Gorbaty, Mayer, Mita, Alain C., Yung, Lotus, Bryan, Peter, McNally, Richard, Renschler, Markus F., Sharma, Sunil
Published in Cancer chemotherapy and pharmacology (01.04.2013)
Published in Cancer chemotherapy and pharmacology (01.04.2013)
Get full text
Journal Article